Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 3 , Pages 260-267 , May 2010

Differential ectonucleotidase expression in human bladder cancer cell lines

  • Joséli Stella, M.Sc.

      Affiliations

    • Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil
    • Recipient of Brazilian Capes fellowship.
    • ,
  • Luci Bavaresco, M.Sc.

      Affiliations

    • Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil
    • ,
  • Elizandra Braganhol, M.Sc.

      Affiliations

    • Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil
    • ,
  • Liliana Rockenbach

      Affiliations

    • Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil
    • ,
  • Patrícia Fernandes Farias

      Affiliations

    • Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil
    • ,
  • Márcia R. Wink, Ph.D.

      Affiliations

    • Departamento de Bioquímica, Ciências Fisiológicas, Fundação Faculdade Federal de Ciências Médicas de Porto Alegre (FFFCMPA), Porto Alegre, Brazil
    • ,
  • Alan A. Azambuja, M.D.

      Affiliations

    • Faculdade de Medicina, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, Brazil
    • ,
  • Carlos Henrique Barrios, M.D.

      Affiliations

    • Faculdade de Medicina, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, Brazil
    • ,
  • Fernanda Bueno Morrone, Ph.D.

      Affiliations

    • Faculdade de Farrmácia, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, Brazil
    • ,
  • Ana Maria Oliveira Battastini, Ph.D.

      Affiliations

    • Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil
    • Corresponding Author InformationCorresponding author. Tel.: +55-51-3308-5553; fax: +55-51-3308-5535

Received 17 November 2008 ,Revised 28 January 2009 ,Accepted 30 January 2009.

References 

  1. Brauers A, Jakse G. Epidemiology and biology of human urinary bladder cancer. J Cancer Res Clin Oncol. 2000;126:575–583
  2. Jemal A, Murray T, Ward E, et al. Cancer statistics. CA Cancer J Clin. 2005;55:10–30
  3. Przybylo M, Litynska A, Pochec E. Different adhesion and migration properties of human HCV29 nonmalignant urothelial and T24 bladder cancer cell: Role of glycosylation. Biochimie. 2005;87:133–142
  4. Heney NM, Ahmed S, Flanagan MJ, et al. Superficial bladder cancer: Progression and recurrence. J Urol. 1983;130:1083–1086
  5. Herr HW, Wartinger WR, Fair WR, et al. Bacillus Calmette-Guerin therapy for superficial bladder cancer: A 10-year follow-up. J Urol. 1992;147:1020–1023
  6. Lamm DL, Thor DE, Harris SC, et al. Bacillus Calmette-Guerin immunotherapy of superficial bladder cancer. J Urol. 1980;124:38–40
  7. Burnstock G. Introduction: P2 receptors. Curr Top Med Chem. 2004;4:793–803
  8. Burnstock G, Knight GE. Cellular distribution and functions of P2 receptor subtypes in different systems. Int Rev Cytol. 2004;240:31–304
  9. Zimmermann H. Ectonucleotidases: Some recent developments and a note on nomenclature. Drug Dev Res. 2001;52:44–56
  10. Zimmermann H. 5′-Nucleotidase-molecular structure and functional aspects. Biochem J. 1992;285:345–365
  11. Robson SC, Sévigny J, Zimmermann H. The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance. Purinergic Signal. 2006;2:409–430
  12. Dzhandzhugazyan KN, Kirkin AF, Straten PT, et al. Ecto-ATP diphosphohydrolase/CD39 is overexpressed in differentiated human melanomas. FEBS Lett. 1998;430:227–230
  13. Kittel A, Garrido M, Vargas G. Localization of NTPDase1/CD39 in normal and transformed human pancreas. J Histochem Cytochem. 2002;50:549–555
  14. Blanquez MI, Areras MI, Conde I, et al. Deregulated expression of the PCPH proto-oncogene in human breast cancers. Int J Oncology. 2004;4:820–830
  15. Ujházy P, Berleth ES, Pietkiewicz JM, et al. Evidence for the involvement of ecto-5′-nucleotidase (CD73) in drug resistance. Int J Cancer. 1996;68:493–500
  16. Spychala J. Tumor-promoting functions of adenosine. Pharmacol Ther. 2000;87:161–173
  17. Wink MR, Lenz G, Braganhol E, et al. Altered extracellular ATP, ADP, and AMP catabolism in glioma cell lines. Cancer Lett. 2003;198:211–218
  18. Morrone FB, Oliveira DL, Gamermann PW, et al. In vivo glioblastoma growth is reduced by apyrase activity in a rat glioma model. BMC Cancer. 2006;6:226–231
  19. Bavaresco L, Bernardi A, Braganhol E, et al. The role of ecto-5′-nucleotidase/CD73 in glioma cell line proliferation. Mol Cell Biochem. 2008;319:61–68
  20. Goding JW, Grobben B, Slegers H. Physiological and pathophysiological functions of ectonucleotide pyrophosphatase/phosphodiesterase family. Biochim Biophys Acta. 2003;1638:1–19
  21. Bollen M, Gijsbers R, Ceulemans H, et al. Nucleotide pyrophosphatases/phosphodiesterases on the move. Crit Rev Biochem Mol Biol. 2000;35:393–432
  22. Ashfaque A, Memon MBBS, Chang JW, et al. Identification of differentially expressed proteins during human urinary bladder cancer progression. Cancer Detect Prev. 2005;29:249–255
  23. Tempest HV, Dixon AK, Turner WH, et al. P2X2 and P2X3 receptor expression in human bladder urothelium and changes in interstitial cystitis. BJU Int. 2004;93:1344–1348
  24. Burnstock G. Purine-mediated signaling in pain and visceral perception. Trends Pharmacol Sci. 2001;22:182–188
  25. Shabbir M, Ryten M, Thompson C, et al. Purinergic receptor-mediated effects of ATP in high-grade bladder cancer. BJU Int. 2007;01:106–112
  26. Chan K, Delgert D, Junger KD. A direct colorimetric assay for Ca2+-ATPase activity. Anal Biochem. 1986;157:375–380
  27. Sakura H, Nagashima S, Nakashima A, et al. Characterization of fetal serum 5′-nucleotide phosphodiesterase: A novel function as a platelet aggregation inhibitor in fetal circulation. Thromb Res. 1998;91:83–89
  28. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254
  29. Elneil S, Skepper JN, Kidd EJ, et al. Distribution of P2X(1) and P2X(3) receptors in the rat and human urinary bladder. Pharmacology. 2001;63:120–128
  30. White N, Burnstock G. P2 receptors and cancer. Trends Pharmacol Sci. 2006;27:211–217
  31. Phelps PT, Anthes JC, Correl CC. Characterization of adenosine receptors in the human bladder carcinoma T24 cell line. Eur J Pharmacol. 2006;536:28–37
  32. Stefan C, Jansen S, Bollen M. NPP-type ectophosphodiesterases unity in diversity. Trends Biochem Sci. 2005;30:542–550
  33. Paez JG, Recio JÁ, Rouzaut A, et al. Identity between the PCPH proto-oncogene and the CD39L4 (NTPDase5) ectonucleoside triphosphate diphosphohydrolase gene. Int J Oncol. 2001;19:1249–1254
  34. Rouzaut A, Recio JA, Notario V. Expression of the protein product of the PCHP proto-oncogene in human tumor cell lines. Radiat Res. 2001;155:181–187
  35. Merighi S, Mirandola P, Varani K, et al. A glance at adenosine receptors: Novel target for antitumor therapy. Pharmacol Ther. 2003;100:31–48
  36. Zhou P, Zhi X, Zhou T, et al. Overexpression of ecto-5′-nucleotidase (CD73) promotes T-47D human breast cancer cells invasion and adhesion to extracellular matrix. Cancer Biol Ther. 2007;6:426–431
  37. Sadej R, Spychala J, Skladanowski AC. Expression of ecto-5′-nucleotidase (eN, CD73) in cell lines from various stages of human melanoma. Melanoma Res. 2006;16:213–222
  38. Burnstock G. Purinergic signaling and disorders of the central nervous s system. Nature Rev. 2008;7:575–590

☆ This study was supported by the Brazilian agencies FAPERGS and CNPq.

PII: S1078-1439(09)00036-2

doi: 10.1016/j.urolonc.2009.01.035

Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 3 , Pages 260-267 , May 2010

Article Tools

* Image Usage & Resolution